Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Scholar Rock Holding Corp (SRRK) Stock Forecast 2025 - AI Price Prediction & Analysis

Scholar Rock Holding Corp (SRRK) AI Stock Price Forecast & Investment Analysis

Scholar Rock Holding Corp Stock Price Chart and Technical Analysis

Loading Scholar Rock Holding Corp interactive price chart and technical analysis...

Scholar Rock Holding Corp (SRRK) - Comprehensive Stock Analysis & Investment Research

Deep dive into Scholar Rock Holding Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Scholar Rock Holding Corp, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Scholar Rock Holding Corp: Scholar Rock Holding Corp operates in the Life Sciences sector, establishing it as a mid-cap growth opportunity.

Scholar Rock Holding Corp (Stock Symbol: SRRK) is a leading company in the Life Sciences sector , specifically operating within the Biological Products, (No Diagnostic Substances) industry.

The organization employs approximately 135 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Scholar Rock Holding Corp's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Scholar Rock Holding Corp: With $62M in annual revenue and -295.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $62 million generating a -295.6% net profit margin .

Market Capitalization: $2844 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -60.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Scholar Rock Holding Corp stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Scholar Rock Holding Corp: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Scholar Rock Holding Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Scholar Rock Holding Corp's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Scholar Rock Holding Corp: Market positioning analysis based on available financial and operational metrics.

Scholar Rock Holding Corp strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

Scholar Rock Holding Corp (SRRK) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Scholar Rock Holding Corp stock analysis.

Loading Scholar Rock Holding Corp comprehensive fundamental analysis and insider trading data...

Deep dive into Scholar Rock Holding Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Scholar Rock Holding Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Scholar Rock Holding Corp: With a P/E ratio of -18.48, the market sees the stock as potentially undervalued.

P/E Ratio -18.48x
P/B Ratio 12.19x
Market Cap $2844M
EPS $-2.35
Book Value/Share $2.43
Revenue/Share $0.41
FCF/Share $-2.04
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Scholar Rock Holding Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Scholar Rock Holding Corp: An ROE of -60.9% indicates room for improvement in shareholder value creation.

ROE -60.9%
ROA -38.1%
ROIC -46.5%
Operating Margin -335.1%
Net Margin -295.6%
EBT Margin -700.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Scholar Rock Holding Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Scholar Rock Holding Corp: A current ratio of 4.13 indicates strong liquidity.

Current Ratio 4.13x
Quick Ratio 3.93x
D/E Ratio 0.40x
Financial Leverage 1.77x
Working Capital $302M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Scholar Rock Holding Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Scholar Rock Holding Corp: Free cash flow of $-132M indicates cash challenges that need attention.

Operating Cash Flow $-127M
Free Cash Flow $-132M
Capital Spending $-5M
FCF/Sales -701.7%
CapEx/Sales 27.9%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Scholar Rock Holding Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Scholar Rock Holding Corp: An asset turnover of 0.05x suggests room for improvement in asset utilization.

Asset Turnover 0.05x
Receivables Turnover 1.2x
Fixed Assets Turnover 0.5x
Days Sales Outstanding 296 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Scholar Rock Holding Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Scholar Rock Holding Corp: With annual revenue of $62M, Scholar Rock Holding Corp represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $62M
R&D Expense $169M
SG&A Expense $214M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 87%
Cash & Short-term Investments 83%
Total Liabilities 43%
Short-term Debt 1%
Accounts Receivable 13%
Dividend & Shareholder Information
Shares Outstanding 96M
Growth Metrics (YoY)
EPS Growth -6.0%

Latest Scholar Rock Holding Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Scholar Rock Holding Corp (SRRK) stock price and investment outlook.

📰 We are currently updating our news feed for Scholar Rock Holding Corp. Check back soon for the latest market analysis and company updates.

Scholar Rock Holding Corp Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Scholar Rock Holding Corp against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABOS Unlock Forecast - 30 Days FREE Trial $129M -1.9x 1.1x
ABP Unlock Forecast - 30 Days FREE Trial $13M x 0.0x
ACLX Unlock Forecast - 30 Days FREE Trial $4997M -74.1x 12.7x
ACOG Unlock Forecast - 30 Days FREE Trial $95M x 3.0x
ADAP Unlock Forecast - 30 Days FREE Trial $80M -13.2x -11.8x
ADMA Unlock Forecast - 30 Days FREE Trial $3693M 17.3x 9.3x
ADPT Unlock Forecast - 30 Days FREE Trial $2643M -4.6x 14.7x
ADVM Unlock Forecast - 30 Days FREE Trial $90M -1.8x 2.2x
AGEN Unlock Forecast - 30 Days FREE Trial $119M -0.5x -0.5x
AGTX Unlock Forecast - 30 Days FREE Trial $2M x x
AIM Unlock Forecast - 30 Days FREE Trial $2M -0.5x -183.3x
AIMI Unlock Forecast - 30 Days FREE Trial $2M x x
ALEC Unlock Forecast - 30 Days FREE Trial $149M -1.2x 2.1x
ALGS Unlock Forecast - 30 Days FREE Trial $48M -19.2x 0.5x
ALLO Unlock Forecast - 30 Days FREE Trial $273M -1.4x 0.8x
AMGN Unlock Forecast - 30 Days FREE Trial $159498M 23.8x 21.5x
APGE Unlock Forecast - 30 Days FREE Trial $3314M -20.5x 4.3x
APTOF Unlock Forecast - 30 Days FREE Trial $3M x x
ARMP Unlock Forecast - 30 Days FREE Trial $169M -1.0x -1.6x
ARTV Unlock Forecast - 30 Days FREE Trial $94M x 0.6x
ATHA Unlock Forecast - 30 Days FREE Trial $164M -0.2x 5.1x
ATRA Unlock Forecast - 30 Days FREE Trial $98M 17.8x -1.1x
ATYR Unlock Forecast - 30 Days FREE Trial $79M -3.6x 1.1x
AURA Unlock Forecast - 30 Days FREE Trial $381M -4.9x 2.2x
AUTL Unlock Forecast - 30 Days FREE Trial $413M x 1.2x
AVXL Unlock Forecast - 30 Days FREE Trial $681M -17.3x 7.5x
BCAB Unlock Forecast - 30 Days FREE Trial $39M -1.1x 1.0x
BCDA Unlock Forecast - 30 Days FREE Trial $8M -0.6x -7.8x
BCLI Unlock Forecast - 30 Days FREE Trial $7M -4.9x -0.9x
BCRX Unlock Forecast - 30 Days FREE Trial $1537M -12.1x -4.0x
BDTX Unlock Forecast - 30 Days FREE Trial $220M 15.8x 1.7x
BEAM Unlock Forecast - 30 Days FREE Trial $2520M -12.6x 2.4x
BIIB Unlock Forecast - 30 Days FREE Trial $22647M 14.4x 1.5x
CABA Unlock Forecast - 30 Days FREE Trial $330M -1.6x 1.9x
CADL Unlock Forecast - 30 Days FREE Trial $295M -4.6x 3.3x
CCCC Unlock Forecast - 30 Days FREE Trial $170M -2.6x 1.0x
CDTX Unlock Forecast - 30 Days FREE Trial $2538M -1.0x 5.1x
CELZ Unlock Forecast - 30 Days FREE Trial $9M -3.4x 1.4x
CERO Unlock Forecast - 30 Days FREE Trial $0M x -196.2x
CGEM Unlock Forecast - 30 Days FREE Trial $512M -4.1x 1.0x
CGEN Unlock Forecast - 30 Days FREE Trial $160M x 3.2x
CGON Unlock Forecast - 30 Days FREE Trial $3299M x 4.9x
CGTX Unlock Forecast - 30 Days FREE Trial $107M -0.5x 15.2x
CHRS Unlock Forecast - 30 Days FREE Trial $195M 1.1x 1.6x
CLDI Unlock Forecast - 30 Days FREE Trial $5M -0.9x 2.6x
CMPX Unlock Forecast - 30 Days FREE Trial $517M -4.8x 5.6x
CRBU Unlock Forecast - 30 Days FREE Trial $225M -1.5x 1.4x
CRDF Unlock Forecast - 30 Days FREE Trial $151M -4.0x 2.6x
CRIS Unlock Forecast - 30 Days FREE Trial $16M -0.3x -2.9x
CRSP Unlock Forecast - 30 Days FREE Trial $5655M -12.1x 3.3x
CSBR Unlock Forecast - 30 Days FREE Trial $93M -17.8x 26.6x
CVM Unlock Forecast - 30 Days FREE Trial $38M -0.9x 5.4x
DBVT Unlock Forecast - 30 Days FREE Trial $2005M -3.3x 37.9x
DNA Unlock Forecast - 30 Days FREE Trial $687M -13.9x 0.4x
DNLI Unlock Forecast - 30 Days FREE Trial $2372M -8.7x 2.3x
DTIL Unlock Forecast - 30 Days FREE Trial $91M -2.2x 5.5x
DYAI Unlock Forecast - 30 Days FREE Trial $33M -7.3x 11.4x
EDIT Unlock Forecast - 30 Days FREE Trial $269M -0.8x 14.0x
ELUT Unlock Forecast - 30 Days FREE Trial $42M -1.4x -0.1x
ENGN Unlock Forecast - 30 Days FREE Trial $368M 3.7x 1.8x
ENTX Unlock Forecast - 30 Days FREE Trial $132M 8.5x 7.7x
ESLA Unlock Forecast - 30 Days FREE Trial $110M -3.1x -16.9x
EXEL Unlock Forecast - 30 Days FREE Trial $10446M 17.1x 5.1x
EXOZ Unlock Forecast - 30 Days FREE Trial $117M x 16.2x
FATE Unlock Forecast - 30 Days FREE Trial $144M -1.3x 0.6x
FDMT Unlock Forecast - 30 Days FREE Trial $537M -3.0x 1.3x
FENC Unlock Forecast - 30 Days FREE Trial $227M 1758.3x -39.7x
FNCH Unlock Forecast - 30 Days FREE Trial $19M -0.1x 1.4x
FTII Unlock Forecast - 30 Days FREE Trial $3M x -0.7x
FTIIU Unlock Forecast - 30 Days FREE Trial $-26M x -0.8x
GILD Unlock Forecast - 30 Days FREE Trial $151586M 23.8x 7.7x
GLUE Unlock Forecast - 30 Days FREE Trial $793M 23.0x 3.0x
GNTA Unlock Forecast - 30 Days FREE Trial $49M x 3.9x
GPLB Unlock Forecast - 30 Days FREE Trial $1M x x
HALO Unlock Forecast - 30 Days FREE Trial $7668M 14.0x 23.0x
HLVX Unlock Forecast - 30 Days FREE Trial $105M -0.6x 0.7x
HUMA Unlock Forecast - 30 Days FREE Trial $261M -3.3x 64.4x
IBRX Unlock Forecast - 30 Days FREE Trial $2198M -3.6x -4.1x
IKT Unlock Forecast - 30 Days FREE Trial $101M -1.0x 1.3x
IMCR Unlock Forecast - 30 Days FREE Trial $1667M x 4.3x
IMVT Unlock Forecast - 30 Days FREE Trial $4222M -14.5x 6.9x
INBX Unlock Forecast - 30 Days FREE Trial $1182M -6.8x 17.2x
INKT Unlock Forecast - 30 Days FREE Trial $54M -1.5x -1.4x
INMB Unlock Forecast - 30 Days FREE Trial $47M -2.5x 1.9x
INTS Unlock Forecast - 30 Days FREE Trial $7M -2.2x 3.1x
IOVA Unlock Forecast - 30 Days FREE Trial $674M -4.5x 1.0x
IPSC Unlock Forecast - 30 Days FREE Trial $52M -0.7x 0.3x
IVVD Unlock Forecast - 30 Days FREE Trial $211M -0.4x 4.9x
JSPR Unlock Forecast - 30 Days FREE Trial $34M -3.2x 1.5x
KLRS Unlock Forecast - 30 Days FREE Trial $90M x 1.7x
KLTO Unlock Forecast - 30 Days FREE Trial $27M x 2.5x
KOD Unlock Forecast - 30 Days FREE Trial $958M -2.5x 13.6x
KRYS Unlock Forecast - 30 Days FREE Trial $5713M 36.7x 5.5x
KYMR Unlock Forecast - 30 Days FREE Trial $4363M -17.8x 4.5x
KYTX Unlock Forecast - 30 Days FREE Trial $301M x 1.6x
LADX Unlock Forecast - 30 Days FREE Trial $0M x x
LCTX Unlock Forecast - 30 Days FREE Trial $438M -4.7x 9.1x
LENZ Unlock Forecast - 30 Days FREE Trial $847M -6.7x 4.1x
LIMN Unlock Forecast - 30 Days FREE Trial $0M x x
LXEO Unlock Forecast - 30 Days FREE Trial $541M -0.4x 3.9x
MAZE Unlock Forecast - 30 Days FREE Trial $1443M x 5.5x
MGTX Unlock Forecast - 30 Days FREE Trial $730M -3.4x 246.8x
MGX Unlock Forecast - 30 Days FREE Trial $90M x 0.5x
MRNA Unlock Forecast - 30 Days FREE Trial $10565M -3.2x 1.1x
NBIX Unlock Forecast - 30 Days FREE Trial $14278M 40.8x 4.8x
NMRA Unlock Forecast - 30 Days FREE Trial $488M -3.9x 2.7x
NVAX Unlock Forecast - 30 Days FREE Trial $1362M 3.2x 36.2x
OCGN Unlock Forecast - 30 Days FREE Trial $456M -4.3x 149.4x
OTLK Unlock Forecast - 30 Days FREE Trial $57M -0.2x -2.3x
PASG Unlock Forecast - 30 Days FREE Trial $23M -0.6x 0.6x
PCVX Unlock Forecast - 30 Days FREE Trial $5878M -20.4x 1.9x
PHGE Unlock Forecast - 30 Days FREE Trial $13M 1.5x 0.7x
PLUR Unlock Forecast - 30 Days FREE Trial $34M -1.4x -9.1x
PLX Unlock Forecast - 30 Days FREE Trial $181M 23.0x 3.6x
PRME Unlock Forecast - 30 Days FREE Trial $664M -1.5x 10.9x
PROK Unlock Forecast - 30 Days FREE Trial $188M x 0.0x
QGEN Unlock Forecast - 30 Days FREE Trial $10528M x 3.0x
QNCX Unlock Forecast - 30 Days FREE Trial $86M -1.7x 7.3x
REPL Unlock Forecast - 30 Days FREE Trial $757M -3.8x 2.3x
RGEN Unlock Forecast - 30 Days FREE Trial $8385M 8219.1x 4.1x
RGNX Unlock Forecast - 30 Days FREE Trial $643M -1.8x 3.0x
RLAY Unlock Forecast - 30 Days FREE Trial $1226M -2.0x 1.8x
RVMD Unlock Forecast - 30 Days FREE Trial $10997M -11.1x 5.9x
RXRX Unlock Forecast - 30 Days FREE Trial $2389M -4.7x 2.6x
SANA Unlock Forecast - 30 Days FREE Trial $1141M -2.1x 9.3x
SCLX Unlock Forecast - 30 Days FREE Trial $91M -0.4x -0.3x
SCNI Unlock Forecast - 30 Days FREE Trial $8479M -287.8x 1079.1x
SGMO Unlock Forecast - 30 Days FREE Trial $143M -1.6x 7.3x
SLDB Unlock Forecast - 30 Days FREE Trial $418M -0.9x 1.6x
SLXN Unlock Forecast - 30 Days FREE Trial $2M x 17.0x
SNTI Unlock Forecast - 30 Days FREE Trial $52M -1.1x 2.1x
SRRK Unlock Forecast - 30 Days FREE Trial $2844M -18.5x 12.2x
SRZN Unlock Forecast - 30 Days FREE Trial $112M -0.5x 2.4x
STRO Unlock Forecast - 30 Days FREE Trial $89M -1.0x -2.5x
TARA Unlock Forecast - 30 Days FREE Trial $191M -2.1x 1.3x
TARS Unlock Forecast - 30 Days FREE Trial $2905M -12.4x 8.7x
TCBPY Unlock Forecast - 30 Days FREE Trial $13M x 11.8x
TCRX Unlock Forecast - 30 Days FREE Trial $144M -4.6x 0.8x
TECX Unlock Forecast - 30 Days FREE Trial $342M -8.9x 1.2x
TIL Unlock Forecast - 30 Days FREE Trial $112M -1.1x 0.9x
TNYA Unlock Forecast - 30 Days FREE Trial $205M -2.5x 2.1x
TRML Unlock Forecast - 30 Days FREE Trial $1233M -3.5x 4.8x
TSHA Unlock Forecast - 30 Days FREE Trial $1353M -3.0x 5.4x
TTNP Unlock Forecast - 30 Days FREE Trial $6M -0.5x 2.2x
TVGN Unlock Forecast - 30 Days FREE Trial $117M x -29.3x
TWST Unlock Forecast - 30 Days FREE Trial $1979M -12.6x 4.1x
VACH Unlock Forecast - 30 Days FREE Trial $67M x 0.0x
VACHU Unlock Forecast - 30 Days FREE Trial $67M x 0.0x
VCEL Unlock Forecast - 30 Days FREE Trial $1768M 257.8x 5.8x
VIR Unlock Forecast - 30 Days FREE Trial $828M -2.0x 0.9x
VOR Unlock Forecast - 30 Days FREE Trial $3029M -0.6x 3.9x
VXRT Unlock Forecast - 30 Days FREE Trial $76M -0.9x 2.3x
VYGR Unlock Forecast - 30 Days FREE Trial $259M 570.6x 1.1x
XFOR Unlock Forecast - 30 Days FREE Trial $33M 6.4x 8.2x
ZIVO Unlock Forecast - 30 Days FREE Trial $48M -31.3x -2.0x

Frequently Asked Questions - Scholar Rock Holding Corp Stock Forecast

How accurate are Scholar Rock Holding Corp stock predictions?

Our AI model shows a 27% Spearman correlation coefficient for SRRK predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Scholar Rock Holding Corp stock price forecasts?

Our analysis considers Scholar Rock Holding Corp's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Scholar Rock Holding Corp a good investment in 2025?

Based on our AI analysis, Scholar Rock Holding Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Scholar Rock Holding Corp forecasts updated?

Scholar Rock Holding Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Scholar Rock Holding Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Scholar Rock Holding Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...